1. GambettiP, KongQ, ZouW, ParchiP, ChenSG (2003) Sporadic and familial CJD: classification and characterisation. Br Med Bull 66: 213–239.
2. BrownP, BrandelJP, SatoT, NakamuraY, MacKenzieJ, et al. (2012) Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis 18: 901–907.
3. AguzziA, ZhuC (2012) Five questions on prion diseases. PLoS Pathog 8: e1002651.
4. JacksonWS (2014) Selective vulnerability to neurodegenerative disease: the curious case of Prion Protein. Dis Model Mech 7: 21–29.
5. WattsJC, PrusinerSB (2014) Mouse Models for Studying the Formation and Propagation of Prions. J Biol Chem 289: 19841–19849.
6. PuotiG, BizziA, ForloniG, SafarJG, TagliaviniF, et al. (2012) Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 11: 618–628.
7. PrusinerSB (2013) Biology and genetics of prions causing neurodegeneration. Annu Rev Genet 47: 601–623.
8. MurrayK, RitchieDL, BruceM, YoungCA, DoranM, et al. (2008) Sporadic Creutzfeldt-Jakob disease in two adolescents. J Neurol Neurosurg Psychiatry 79: 14–18.
9. MoschB, MorawskiM, MittagA, LenzD, TarnokA, et al. (2007) Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease. J Neurosci 27: 6859–6867.
10. WattsJC, GilesK, StohrJ, OehlerA, BhardwajS, et al. (2012) Spontaneous generation of rapidly transmissible prions in transgenic mice expressing wild-type bank vole prion protein. Proc Natl Acad Sci U S A 109: 3498–3503.
11. AgostiniF, DottiCG, Perez-CanamasA, LedesmaMD, BenettiF, et al. (2013) Prion protein accumulation in lipid rafts of mouse aging brain. PLoS ONE 8: e74244.
12. GibbsCJJr, AsherDM, KobrineA, AmyxHL, SulimaMP, et al. (1994) Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. J Neurol Neurosurg Psychiatry 57: 757–758.
13. HillAF, ButterworthRJ, JoinerS, JacksonG, RossorMN, et al. (1999) Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353: 183–189.
14. JacksonWS, BorkowskiAW, WatsonNE, KingOD, FaasH, et al. (2013) Profoundly different prion diseases in knock-in mice carrying single PrP codon substitutions associated with human diseases. Proc Natl Acad Sci U S A 110: 14759–14764.
15. BarriaMA, MukherjeeA, Gonzalez-RomeroD, MoralesR, SotoC (2009) De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog 5: e1000421.
16. TrueHL, LindquistSL (2000) A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407: 477–483.
17. SiK, LindquistS, KandelER (2003) A neuronal isoform of the aplysia CPEB has prion-like properties. Cell 115: 879–891.
18. AlbertiS, HalfmannR, KingO, KapilaA, LindquistS (2009) A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 137: 146–158.
19. KingOD, GitlerAD, ShorterJ (2012) The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res 1462: 61–80.
20. SilvaJL, RangelLP, CostaDC, CordeiroY, De Moura GalloCV (2013) Expanding the prion concept to cancer biology: dominant-negative effect of aggregates of mutant p53 tumour suppressor. Biosci Rep 33: e00054.
21. CaiX, ChenJ, XuH, LiuS, JiangQX, et al. (2014) Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 156: 1207–1222.
22. FranklinBS, BossallerL, De NardoD, RatterJM, StutzA, et al. (2014) The adaptor ASC has extracellular and ‘prionoid’ activities that propagate inflammation. Nat Immunol 15: 727–737.
23. KaneMD, LipinskiWJ, CallahanMJ, BianF, DurhamRA, et al. (2000) Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice. J Neurosci 20: 3606–3611.
24. Meyer-LuehmannM, CoomaraswamyJ, BolmontT, KaeserS, SchaeferC, et al. (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313: 1781–1784.
25. LukKC, KehmVM, ZhangB, O'BrienP, TrojanowskiJQ, et al. (2012) Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med 209: 975–986.
26. LiJY, EnglundE, HoltonJL, SouletD, HagellP, et al. (2008) Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 14: 501–503.
27. AsheKH, AguzziA (2013) Prions, prionoids and pathogenic proteins in Alzheimer disease. Prion 7: 55–59.
28. MallucciG, DickinsonA, LinehanJ, KlohnPC, BrandnerS, et al. (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302: 871–874.
29. WagnerJ, RyazanovS, LeonovA, LevinJ, ShiS, et al. (2013) Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease. Acta Neuropathol 125: 795–813.